Evidence map›Paper›PMID 26638071›Full record

ArticleCell2015

Redox Signaling by the RNA Polymerase III TFIIB-Related Factor Brf2.

Jerome Gouge, Karishma Satia, Nicolas Guthertz, Marcella Widya, Andrew James Thompson, Pascal Cousin, Oleksandr Dergai, Nouria Hernandez, Alessandro Vannini

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Dissecting the Interplay Between NRF2 and BACH1 at CsMBEs.Antioxidants (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Jerome GougeDivision of Structural Biology, The Institute of Cancer Research, London SW7 3RP, UK.
Karishma SatiaDivision of Structural Biology, The Institute of Cancer Research, London SW7 3RP, UK.
Nicolas GuthertzDivision of Structural Biology, The Institute of Cancer Research, London SW7 3RP, UK.
Marcella WidyaDivision of Structural Biology, The Institute of Cancer Research, London SW7 3RP, UK.
Andrew James ThompsonDivision of Structural Biology, The Institute of Cancer Research, London SW7 3RP, UK.
Pascal CousinCenter for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland.
Oleksandr DergaiCenter for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland.
Nouria HernandezCenter for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland.
Alessandro VanniniDivision of Structural Biology, The Institute of Cancer Research, London SW7 3RP, UK. Electronic address: alessandro.vannini@icr.ac.uk.
Institute of Cancer Research · GBUniversity of Lausanne · CH

Funding

Biotechnology and Biological Sciences Research Council BB/K014390/1
6 · The paper itself

Abstract

TFIIB-related factor 2 (Brf2) is a member of the family of TFIIB-like core transcription factors. Brf2 recruits RNA polymerase (Pol) III to type III gene-external promoters, including the U6 spliceosomal RNA and selenocysteine tRNA genes. Found only in vertebrates, Brf2 has been linked to tumorigenesis but the underlying mechanisms remain elusive. We have solved crystal structures of a human Brf2-TBP complex bound to natural promoters, obtaining a detailed view of the molecular interactions occurring at Brf2-dependent Pol III promoters and highlighting the general structural and functional conservation of human Pol II and Pol III pre-initiation complexes. Surprisingly, our structural and functional studies unravel a Brf2 redox-sensing module capable of specifically regulating Pol III transcriptional output in living cells. Furthermore, we establish Brf2 as a central redox-sensing transcription factor involved in the oxidative stress pathway and provide a mechanistic model for Brf2 genetic activation in lung and breast cancer.

Indexed as

Oxidation-ReductionAmino Acid SequenceAnimalsCrystallography, X-RayDNAHumansMiceModels, MolecularMolecular Sequence DataRNA Polymerase IIISaccharomyces cerevisiaeSequence AlignmentSignal TransductionTranscription Factor TFIIIBBRF2 protein, humanDNARNA Polymerase IIITranscription Factor TFIIIB

Identifiers

PMID26638071
PMCPMC4671959
OpenAlexW2185888398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.